{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:26:11Z","timestamp":1784748371148,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.abb.2021.109048","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T12:56:05Z","timestamp":1633006565000},"page":"109048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Unravelling the antifungal mode of action of curcumin by potential inhibition of CYP51B: A computational study validated in vitro on mucormycosis agent, Rhizopus oryzae"],"prefix":"10.1016","volume":"712","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8700-9929","authenticated-orcid":false,"given":"Jignesh","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-8249","authenticated-orcid":false,"given":"Priyashi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6272-8732","authenticated-orcid":false,"given":"Lipi","family":"Poojara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-0294","authenticated-orcid":false,"given":"Dweipayan","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2001-7160","authenticated-orcid":false,"given":"Dhaval","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-1322","authenticated-orcid":false,"given":"Saumya K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7985-1187","authenticated-orcid":false,"given":"Rakesh M.","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2021.109048_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184606","article-title":"Bioactivity of curcumin on the cytochrome P450 enzymes of the steroidogenic pathway","volume":"20","author":"Casta\u00f1o","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.abb.2021.109048_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep06587","article-title":"Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex vivo studies","volume":"4","author":"Hsieh","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2021.109048_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jac\/dkn488","article-title":"Curcumin as a promising antifungal of clinical interest","volume":"63","author":"Martins","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.abb.2021.109048_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201900624","article-title":"Quinoline based monocarbonyl curcumin analogs as potential antifungal and antioxidant agents: synthesis, bioevaluation and molecular docking study","volume":"17","author":"Nagargoje","year":"2020","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.abb.2021.109048_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37330-y","article-title":"Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs","volume":"9","author":"Jeffreys","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2021.109048_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389200023337054","article-title":"The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans","volume":"3","author":"Danielson","year":"2005","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.abb.2021.109048_bib7","article-title":"Preface to volume 3: the ubiquitous roles of cytochrome P450 proteins","volume":"3","author":"Sigel","year":"2007","journal-title":"Met. Ions Life Sci."},{"key":"10.1016\/j.abb.2021.109048_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1517\/phgs.5.3.305.29827","article-title":"57 varieties: the human cytochromes P450","volume":"5","author":"Lewis","year":"2004","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.abb.2021.109048_bib9","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1074\/jbc.R112.431916","article-title":"Cytochromes P450: roles in diseases","volume":"288","author":"Pikuleva","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2021.109048_bib10","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1021\/cr020443g","article-title":"Mechanism of oxidation reactions catalyzed by cytochrome P450 enzymes","volume":"104","author":"Meunier","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.abb.2021.109048_bib11","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The essential medicinal chemistry of curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2021.109048_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/17425255.2019.1650914","article-title":"Is curcumin bioavailability a problem in humans: lessons from clinical trials","volume":"15","author":"Kunnumakkara","year":"2019","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.abb.2021.109048_bib13","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1124\/dmd.108.020552","article-title":"Curcuminoids inhibit multiple human cytochromes P450, UDP- glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor","volume":"36","author":"Volak","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.abb.2021.109048_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/00498250701534877","article-title":"In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes","volume":"37","author":"Lee","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.abb.2021.109048_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1081\/DMR-120018248","article-title":"Interactions of herbs with cytochrome P450","volume":"35","author":"Zhou","year":"2003","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.abb.2021.109048_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.etp.2017.02.009","article-title":"Curcuma longa Linn. extract and curcumin protect CYP 2E1 enzymatic activity against mercuric chloride-induced hepatotoxicity and oxidative stress: a protective approach","volume":"69","author":"Joshi","year":"2017","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.abb.2021.109048_bib17","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1021\/acs.jpca.6b01434","article-title":"Quantum chemical and docking insights into bioavailability enhancement of curcumin by piperine in pepper","volume":"120","author":"Patil","year":"2016","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.abb.2021.109048_bib18","first-page":"75","article-title":"Construction of in silico structure-based screening tools to study the oxidative metabolites formation of curcumin by human cytochrome 450 3A4","volume":"24","author":"Setyaningsih","year":"2013","journal-title":"Indonesian Journal of Pharmacy"},{"key":"10.1016\/j.abb.2021.109048_bib19","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s00894-011-1275-1","article-title":"Exploration of the binding of curcumin analogues to human P450 2C9 based on docking and molecular dynamics simulation","volume":"18","author":"Shi","year":"2012","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.abb.2021.109048_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00253-012-4195-9","article-title":"Fungal cytochrome P450 sterol 14\u03b1-demethylase (CYP51) and azole resistance in plant and human pathogens","volume":"95","author":"Becher","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.abb.2021.109048_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0009-2797(99)00169-6","article-title":"Differential inhibition of human CYP3A4 and Candida albicans CYP51 with azole antifungal agents","volume":"125","author":"Lamb","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.abb.2021.109048_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1124\/dmd.118.082032","article-title":"Comparison of antifungal azole interactions with adult cytochrome P450 3A4 versus neonatal cytochrome P450 3A7","volume":"46","author":"Godamudunage","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.abb.2021.109048_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/00498254.2011.631224","article-title":"Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes","volume":"42","author":"Zhang","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.abb.2021.109048_bib24","first-page":"135","volume":"vol. 27","author":"Sievers","year":"2017"},{"key":"10.1016\/j.abb.2021.109048_bib25","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"Molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.abb.2021.109048_bib26","doi-asserted-by":"crossref","first-page":"P28","DOI":"10.1186\/1471-2105-6-S3-P28","article-title":"Jalview: visualization and analysis of molecular sequences, alignments, and structures","volume":"6","author":"Waterhouse","year":"2005","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.abb.2021.109048_bib27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J J. Comput. Chem."},{"key":"10.1016\/j.abb.2021.109048_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","article-title":"Toward the estimation of the absolute quality of individual protein structure models","volume":"27","author":"Benkert","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.abb.2021.109048_bib29","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.abb.2021.109048_bib30","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.abb.2021.109048_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"A software program for pKa prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.abb.2021.109048_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.abb.2021.109048_bib33","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/ja00214a001","article-title":"The OPLS potential functions for proteins. Energy minimizations for crystals of cyclic peptides and crambin","volume":"110","author":"Jorgensen","year":"1988","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2021.109048_bib34","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.abb.2021.109048_bib35","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.abb.2021.109048_bib36","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2021.109048_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New method for fast and accurate binding-site identification and analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.abb.2021.109048_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev.biophys.30.1.211","article-title":"Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions","volume":"30","author":"Wang","year":"2001","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.abb.2021.109048_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/157340906778226454","article-title":"Recent advances in free energy calculations with a combination of molecular mechanics and continuum models","volume":"2","author":"Wang","year":"2006","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.abb.2021.109048_bib40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.abb.2021.109048_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1008763014207","article-title":"Combined molecular mechanical and continuum solvent approach (MM- PBSA\/GBSA) to predict ligand binding","volume":"18","author":"Massova","year":"2000","journal-title":"Perspect. Drug Discov. Des."},{"key":"10.1016\/j.abb.2021.109048_bib42","first-page":"1","article-title":"In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19","author":"Chikhale","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2021.109048_bib43","series-title":"Proc. 2006 ACM\/IEEE Conf. Supercomput. SC\u201906","first-page":"84","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"10.1016\/j.abb.2021.109048_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104248","article-title":"Structural deformation in pathogenic bacteria cells caused by marine fungal metabolites: an in vitro investigation: structural deformation by marine fungal metabolites","volume":"146","author":"Agrawal","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.abb.2021.109048_bib45","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/0045-6535(89)90512-2","article-title":"The usefulness of the agar-well diffusion method for assessing chemical toxicity to bacteria and fungi","volume":"19","author":"Devillers","year":"1989","journal-title":"Chemosphere"},{"key":"10.1016\/j.abb.2021.109048_bib46","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1128\/JCM.43.4.1917-1920.2005","article-title":"Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum","volume":"43","author":"Santos","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.abb.2021.109048_bib47","doi-asserted-by":"crossref","first-page":"39611","DOI":"10.1039\/C8RA08426B","article-title":"1,2,3-Triazole-quinazolin-4(3H)-one conjugates: evolution of ergosterol inhibitor as anticandidal agent","volume":"8","author":"Masood","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.abb.2021.109048_bib48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/jam.13612","article-title":"Carvacrol and eugenol effectively inhibit Rhizopus stolonifer and control postharvest soft rot decay in peaches","volume":"124","author":"Zhou","year":"2018","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.abb.2021.109048_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9387102","article-title":"Synthesis, molecular docking studies, and antifungal activity evaluation of new benzimidazole-triazoles as potential lanosterol 14\u03b1 -demethylase inhibitors","author":"Can","year":"2017","journal-title":"J. Chem."},{"key":"10.1016\/j.abb.2021.109048_bib50","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00203-019-01781-2","article-title":"Inhibition of ergosterol synthesis in Candida albicans by novel eugenol tosylate congeners targeting sterol 14\u03b1-demethylase (CYP51) enzyme","volume":"202","author":"Lone","year":"2020","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.abb.2021.109048_bib51","first-page":"285","article-title":"Antifungal drugs, side eff","volume":"41","author":"McManus","year":"2019","journal-title":"Drugs Annu"},{"key":"10.1016\/j.abb.2021.109048_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases\u2014estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J. Fungi"},{"key":"10.1016\/j.abb.2021.109048_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00265-4","article-title":"Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?","author":"Raut","year":"2021","journal-title":"Lancet Respir"},{"key":"10.1016\/j.abb.2021.109048_bib54","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.abb.2021.109048_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/jof6010028","article-title":"Aspiring antifungals: review of current antifungal pipeline developments","volume":"6","author":"Gintjee","year":"2020","journal-title":"J. Fungi."},{"key":"10.1016\/j.abb.2021.109048_bib56","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1093\/infdis\/jix130","article-title":"Novel agents and drug targets to meet the challenges of resistant fungi","volume":"216","author":"McCarthy","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.abb.2021.109048_bib57","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1093\/mmy\/myz012","article-title":"Antifungal drugs: what brings the future?","volume":"57","author":"Van Daele","year":"2019","journal-title":"Med. Mycol."},{"key":"10.1016\/j.abb.2021.109048_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.00912","article-title":"Anti-infective properties of the golden spice curcumin","volume":"10","author":"Praditya","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.abb.2021.109048_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104568","article-title":"Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation","author":"Prajapati","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.abb.2021.109048_bib60","article-title":"Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CLpro of novel coronavirus SARS-CoV-2 identified using docking and molecular dynamics","author":"Rao","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2021.109048_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-96963-8","article-title":"Revealing the molecular interplay of curcumin as Culex pipiens Acetylcholine esterase 1 (AChE1) inhibitor","volume":"11","author":"Rao","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2021.109048_bib62","doi-asserted-by":"crossref","first-page":"29015","DOI":"10.1039\/D1RA04460E","article-title":"Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow","volume":"11","author":"Goswami","year":"2021","journal-title":"RSC Adv."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986121002976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986121002976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:04:00Z","timestamp":1762088640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986121002976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":62,"alternative-id":["S0003986121002976"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2021.109048","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling the antifungal mode of action of curcumin by potential inhibition of CYP51B: A computational study validated in vitro on mucormycosis agent, Rhizopus oryzae","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2021.109048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109048"}}